How do you shuffle more than $30 billion between Dublin and the Japanese city of Osaka? In the case of Takeda, the Japanese drug giant, the answer comes through a string of interrelated corporate transactions involving share allocations, shareholders declarations and the appointment of liquidators. On January 30, Takeda pulled down the shutters on a company called Shire Pharmaceutical Holdings Ireland, a 12-year-old holding company that was, until last year, located in the Miesian Plaza, the gleaming office development on the site of the old Bank of Ireland headquarters in Dublin 2. The company had been incorporated by the drug…

Want to continue reading?

Introductory offer: Sign up today and pay €200 for an annual membership, a saving of €100.

Subscribe

Cancel anytime.

Are you already a member? .